Search Results - "Stivers, Katlin B."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Familial hypercholesterolemia class II low-density lipoprotein receptor response to statin treatment by Omer, Linda, Hindi, Lubna, Militello, Giuseppe, Stivers, Katlin B, Tien, Kenneth C, Boyd, Nolan L

    Published in Disease models & mechanisms (06-04-2020)
    “…Low-density lipoprotein (LDL) receptor (LDLR) mutations are the primary cause of familial hypercholesterolemia (FH). Class II LDLR mutations result in a…”
    Get full text
    Journal Article
  2. 2

    Regulating the proinflammatory response to composite biomaterials by targeting immunometabolism by Maduka, Chima V., Makela, Ashley V., Tundo, Anthony, Ural, Evran, Stivers, Katlin B., Kuhnert, Maxwell M., Alhaj, Mohammed, Hoque Apu, Ehsanul, Ashammakhi, Nureddin, Hankenson, Kurt D., Narayan, Ramani, Elisseeff, Jennifer H., Contag, Christopher H.

    Published in Bioactive materials (01-10-2024)
    “…Composite biomaterials comprising polylactide (PLA) and hydroxyapatite (HA) are applied in bone, cartilage and dental regenerative medicine, where HA confers…”
    Get full text
    Journal Article
  3. 3

    Adipose‐resident myeloid‐derived suppressor cells modulate immune cell homeostasis in healthy mice by Stivers, Katlin B, Chilton, Paula M, Beare, Jason E, Dale, Jacob R, Alard, Pascale, LeBlanc, Amanda J, Hoying, James B

    Published in Immunology and cell biology (01-09-2020)
    “…The metabolically dynamic nature of healthy adipose places this tissue under regular inflammatory stress. A network of adipose‐resident anti‐inflammatory…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Adipose-derived cellular therapies in solid organ and vascularized-composite allotransplantation by Stivers, Katlin B., Beare, Jason E., Chilton, Paula M., Williams, Stuart K., Kaufman, Christina L., Hoying, James B.

    Published in Current opinion in organ transplantation (01-10-2017)
    “…Controlling acute allograft rejection following vascularized composite allotransplantation requires strict adherence to courses of systemic immunosuppression…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Familial hypercholesterolemia class II low density lipoprotein-receptor response to statin treatment by Omer, Linda, Hindi, Lubna, Militello, Giuseppe, Stivers, Katlin B, Tien, Kenneth C, Boyd, Nolan L

    Published in Disease models & mechanisms (01-01-2020)
    “…LDL receptor (LDLR) mutations are the primary cause of familial hypercholesterolemia (FH). Class II LDLR mutations result in a misfolded LDLR retained in the…”
    Get full text
    Journal Article